{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:16:40Z","timestamp":1780049800391,"version":"3.53.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T00:00:00Z","timestamp":1549065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00774-019-00987-0","type":"journal-article","created":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T09:51:12Z","timestamp":1549101072000},"page":"796-804","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Novel bisphosphonate compound FYB-931 preferentially inhibits aortic calcification in vitamin D3-treated rats"],"prefix":"10.1007","volume":"37","author":[{"given":"Koichi","family":"Ishida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ashizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Kobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shigematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Iwanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,2]]},"reference":[{"key":"987_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/ki.2013.271","volume":"85","author":"Y Fang","year":"2014","unstructured":"Fang Y, Ginsberg C, Sugatani T, Monier-Faugere MC, Malluche H, Hruska KA (2014) Early chronic kidney disease-mineral bone disorder stimulates vascular calcification. Kidney Int 85:142\u2013150","journal-title":"Kidney Int"},{"key":"987_CR2","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1097\/01.ASN.0000145894.57533.C4","volume":"15","author":"CM Giachelli","year":"2004","unstructured":"Giachelli CM (2004) Vascular calcification mechanisms. J Am Soc Nephrol 15:2959\u20132964","journal-title":"J Am Soc Nephrol"},{"key":"987_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0002-9440(10)65313-8","volume":"154","author":"CM Giachelli","year":"1999","unstructured":"Giachelli CM (1999) Ectopic calcification: gathering hard facts about soft tissue mineralization. Am J Pathol 154:671\u2013675","journal-title":"Am J Pathol"},{"key":"987_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s10157-003-0260-0","volume":"8","author":"M Matsuoka","year":"2004","unstructured":"Matsuoka M, Iseki K, Tamashiro M, Fujimoto N, Higa N, Touma T, Takishita S (2004) Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 8:54\u201358","journal-title":"Clin Exp Nephrol"},{"key":"987_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/jcdd2030141","volume":"2","author":"AJ Yiu","year":"2015","unstructured":"Yiu AJ, Callaghan D, Sultana R, Bandyopadhyay BC (2015) Vascular calcification and stone disease: a new look towards the mechanism. J Cardiovasc Dev Dis 2:141\u2013164","journal-title":"J Cardiovasc Dev Dis"},{"key":"987_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12659\/MSM.882181","volume":"18","author":"W Karwowski","year":"2012","unstructured":"Karwowski W, Naumnik B, Szczepa\u0144ski M, My\u015bliwiec M (2012) The mechanism of vascular calcification: a systematic review. Med Sci Monit 18:1\u201311","journal-title":"Med Sci Monit"},{"key":"987_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00223-013-9712-z","volume":"93","author":"M Wu","year":"2013","unstructured":"Wu M, Rementer C, Giachelli CM (2013) Vascular calcification: an update on mechanisms and challenges in treatment. Calcif Tissue Int 93:365\u2013373","journal-title":"Calcif Tissue Int"},{"key":"987_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1526-0968.2004.00136.x","volume":"8","author":"H Hashiba","year":"2004","unstructured":"Hashiba H, Aizawa S, Tamura K, Shigemastu T, Kogo H (2004) Inhibitory effects of etidronate on the progression of vascular calcification in hemodialysis patients. Ther Apher Dial 8:241\u2013247","journal-title":"Ther Apher Dial"},{"key":"987_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1744-9987.2006.00345.x","volume":"10","author":"H Hashiba","year":"2006","unstructured":"Hashiba H, Aizawa S, Tamura K, Kogo H (2006) Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects. Ther Apher Dial 10:59\u201364","journal-title":"Ther Apher Dial"},{"key":"987_CR10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0272-6386(04)00937-0","volume":"44","author":"K Nitta","year":"2004","unstructured":"Nitta K, Akiba T, Suzuki K, Uchida K, Watanabe R, Majima K, Aoki T, Nihei H (2004) Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis 44:680\u2013688","journal-title":"Am J Kidney Dis"},{"key":"987_CR11","first-page":"2793","volume":"85","author":"H Koshiyama","year":"2000","unstructured":"Koshiyama H, Nakamura Y, Tanaka S, Minamikawa J (2000) Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes. J Clin Endocrinol Metab 85:2793\u20132796","journal-title":"J Clin Endocrinol Metab"},{"key":"987_CR12","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","volume":"12","author":"N Bucay","year":"1998","unstructured":"Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260\u20131268","journal-title":"Genes Dev"},{"key":"987_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/01.ATV.21.5.817","volume":"21","author":"PA Price","year":"2001","unstructured":"Price PA, Faus SA, Williamson MK (2001) Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 21:817\u2013824","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"987_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1053\/j.ajkd.2009.12.039","volume":"56","author":"ND Toussaint","year":"2010","unstructured":"Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG (2010) Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial. Am J Kidney Dis 56:57\u201368","journal-title":"Am J Kidney Dis"},{"key":"987_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s00198-004-1662-x","volume":"16","author":"LB Tank\u00f3","year":"2005","unstructured":"Tank\u00f3 LB, Qin G, Alexandersen P, Bagger YZ, Christiansen C (2005) Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women. Osteoporos Int 16:184\u2013190","journal-title":"Osteoporos Int"},{"key":"987_CR16","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/ki.2011.212","volume":"80","author":"E Zavaczki","year":"2011","unstructured":"Zavaczki E, Jeney V, Agarwal A, Zarjou A, Oros M, Katk\u00f3 M, Varga Z, Balla G, Balla J (2011) Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells. Kidney Int 80:731\u2013739","journal-title":"Kidney Int"},{"key":"987_CR17","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1038\/s41598-017-07203-x","volume":"7","author":"MD Ferrer","year":"2017","unstructured":"Ferrer MD, P\u00e9rez MM, C\u00e0naves MM, Buades JM, Salcedo C, Perell\u00f3 J (2017) A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma. Sci Rep 7:6858","journal-title":"Sci Rep"},{"key":"987_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aal1669","volume":"9","author":"SG Ziegler","year":"2017","unstructured":"Ziegler SG, Ferreira CR, MacFarlane EG, Riddle RC, Tomlinson RE, Chew EY, Martin L, Ma CT, Sergienko E, Pinkerton AB, Mill\u00e1n JL, Gahl WA, Dietz HC (2017) Ectopic calcification in pseudoxanthoma elasticum responds to inhibition of tissue-nonspecific alkaline phosphatase. Sci Transl Med 9:1\u201325","journal-title":"Sci Transl Med"},{"key":"987_CR19","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1021\/jm0702884","volume":"50","author":"MS Marma","year":"2007","unstructured":"Marma MS, Xia Z, Stewart C, Coxon F, Dunford JE, Baron R, Kashemirov BA, Ebetino FH, Triffitt JT, Russell RG, McKenna CE (2007) Synthesis and biological evaluation of \u03b1-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate. J Med Chem 50:5967\u20135975","journal-title":"J Med Chem"},{"key":"987_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bonekey.2013.229","volume":"3","author":"N Takahashi","year":"2014","unstructured":"Takahashi N, Udagawa N, Suda T (2014) Vitamin D endocrine system and osteoclasts. Bonekey Rep 3:1\u20139","journal-title":"Bonekey Rep"},{"key":"987_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2362.1970.tb00591.x","volume":"1","author":"HA Fleisch","year":"1970","unstructured":"Fleisch HA, Russell RGG, Bisaz S, M\u00fchlbauer RC, Williams DA (1970) The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo. Eur J Clin Invest 1:12\u201318","journal-title":"Eur J Clin Invest"},{"key":"987_CR22","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1253\/circj.71.1152","volume":"71","author":"F Grases","year":"2007","unstructured":"Grases F, Sanchis P, Perell\u00f3 J, Isern B, Prieto RM, Fern\u00e1ndez-Palomeque C, Torres JJ (2007) Effect of crystallization inhibitors on vascular calcifications induced by vitamin D: A pilot study in Sprague-Dawley rats. Circ J 71:1152\u20131156","journal-title":"Circ J"},{"key":"987_CR23","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.bbrc.2009.07.085","volume":"387","author":"X Duan","year":"2009","unstructured":"Duan X, Zhou Y, Teng X, Tang C, Qi Y (2009) Endoplasmic reticulum stress-mediated apoptosis is activated in vascular calcification. Biochem Biophys Res Commun 387:694\u2013699","journal-title":"Biochem Biophys Res Commun"},{"key":"987_CR24","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1093\/jn\/131.11.2910","volume":"131","author":"PA Price","year":"2001","unstructured":"Price PA, Buckley JR, Williamson MK (2001) The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats. J Nutr 131:2910\u20132915","journal-title":"J Nutr"},{"key":"987_CR25","doi-asserted-by":"publisher","first-page":"F1212","DOI":"10.1152\/ajprenal.00169.2010","volume":"299","author":"F Saji","year":"2010","unstructured":"Saji F, Shigematsu T, Sakaguchi T, Ohya M, Orita H, Maeda Y, Ooura M, Mima T, Negi S (2010) Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH. Am J Physiol Renal Physiol 299:F1212\u2013F1217","journal-title":"Am J Physiol Renal Physiol"},{"key":"987_CR26","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1007\/s00198-003-1468-2","volume":"14","author":"A Boskey","year":"2003","unstructured":"Boskey A (2003) Bone mineral crystal size. Osteoporos Int 14:S16\u2013S21","journal-title":"Osteoporos Int"},{"key":"987_CR27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ki.2008.663","volume":"75","author":"EG Neven","year":"2009","unstructured":"Neven EG, De Broe ME, D\u2019Haese PC (2009) Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge? Kidney Int 75:580\u2013582","journal-title":"Kidney Int"},{"key":"987_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3892\/mmr.2013.1489","volume":"8","author":"S Zhou","year":"2013","unstructured":"Zhou S, Fang X, Xin H, Guan S (2013) Effects of alendronate on the Notch1-RBP-Jk signaling pathway in the osteogenic differentiation and mineralization of vascular smooth muscle cells. Mol Med Rep 8:89\u201394","journal-title":"Mol Med Rep"},{"key":"987_CR29","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3892\/etm.2012.501","volume":"3","author":"ML Hu","year":"2012","unstructured":"Hu ML, Huang Y, Zheng ZH, Lei Y, Liu RJ, Wang XH, Lindholm B, Yu XQ (2012) Zoledronate inhibits phosphate and bone morphogenic protein 2-induced extracellular calcification of vascular smooth muscle cells in vitro. Exp Ther Med 3:841\u2013844","journal-title":"Exp Ther Med"},{"key":"987_CR30","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1016\/j.biomaterials.2010.01.016","volume":"31","author":"T Masuzaki","year":"2010","unstructured":"Masuzaki T, Ayukawa Y, Moriyama Y, Jinno Y, Atsuta I, Ogino Y, Koyano K (2010) The effect of a single remote injection of statin-impregnated poly (lactic-co-glycolic acid) microspheres on osteogenesis around titanium implants in rat tibia. Biomaterials 31:3327\u20133334","journal-title":"Biomaterials"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-019-00987-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-019-00987-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-019-00987-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,2]],"date-time":"2020-02-02T00:21:37Z","timestamp":1580602897000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-019-00987-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,2]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1007\/s00774-019-00987-0","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,2]]},"assertion":[{"value":"28 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Takashi Shigematsu serves as a consultant for Fuji Yakuhin. The manuscript does not contain clinical studies or patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}